Alpine Immune Sciences (ALPN) Reports FY Loss of $0.64

Alpine Immune Sciences (NASDAQ: ALPN) reported FY EPS of ($0.64). Revenue for the period in at $58.9 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• Is the global equity rally broadening? UBS weighs in
• BMO starts chip stocks coverage: Here are its preferred picks